CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 101-112

  Coraci, Indra Sethy ^a   Husemann, Jens ^a   Berman, Joan W ^b   Hulette, Christine ^c   Dufour, Jennifer H ^d   Campanella, Gabriele K ^d   Luster, Andrew D ^d   Silverstein, Samuel C ^a   El Khoury, Joseph B ^d  

^a College of Physicians and Surgeons ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CD36 ANTIGEN; COMPLEMENTARY DNA; HYDROGEN PEROXIDE; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL SELECTION; CONTROLLED STUDY; DNA TRANSFECTION; FETUS; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROGLIA; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SENILE PLAQUE; VASCULAR ENDOTHELIUM;

EID: 0036141148     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64354-4     Document Type: Article

References (53)

1. The origins of Alzheimer disease: A is for amyloid
2. Neuropathological diagnosis of Alzheimer disease
3. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease
4. Inflammatory response in Alzheimer's disease
5. Activation of microglial cells by beta-amyloid protein and interferon-gamma
6. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils
7. Beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease
8. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia
9. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS
10. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor
11. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease
12. Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease
13. Aβ-induced inflammatory processes in microglia cells of APP23 transgenic mice
14. CD36 is a receptor for oxidized low density lipoprotein
15. 2
16. Growth kinetics, cell shape, and the cytoskeleton of primary astrocyte cultures
17. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene
18. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia
19. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors
20. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
21. In vitro studies of β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease
22. A simple method for the solubilisation of reduced NBT, and its use as a calorimetric assay for activation of human macrophages by gamma-interferon
23. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells
24. Inflammatory glia mediate delayed neurenal damage after ischemia in the central nervous system
25. Ultrastructural localization of monosaccharide residues on cerebral endothelium
26. A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology
27. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
28. Amyloid-like properties of a synthetic peptide corresponding to the carboxy terminus of beta-amyloid protein precursor
29. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation
30. Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates
31. Isolation of the thrombospondin membrane receptor
32. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
33. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system
34. Brain microglia constitutively express beta-2 integrins
35. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type
36. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators
37. Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease
38. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells
39. Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction
40. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid
41. Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice
42. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study
43. Cerebral amyloid angiopathy in dementia and old age
44. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes
45. Evidence of blood-brain barrier dysfunction in human cerebral malaria
46. Ultrastructural features of the blood brain barrier in biopsy tissue from Alzheimer's disease patients
47. Beta-Amyloid-mediated vasoactivity and vascular endothelial damage
48. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in A-POE3 Leiden transgenic mice
49. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
50. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors
51. Microglial response to amyloid plaques in APPsw transgenic mice
52. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease
53. Targeted disruption of the class B scavenger receptor CD36 protects against atheresclerotic lesion development in mice